CP-25, a Novel Anti-inflammatory and Immunomodulatory Drug, Inhibits the Functions of Activated Human B Cells through Regulating BAFF and TNF-alpha Signaling and Comparative Efficacy with Biological Agents

Feng Zhang(First Affiliated Hospital of Zhengzhou University), Wei Wei(Anhui Medical University)
Frontiers in Pharmacology
December 22, 2017
Cited by 28


Related Papers